Development of Metal–Organic Frameworks (ZIF-8) as Low-Cost Carriers for Sustained Release of Hydrophobic and Hydrophilic Drugs: In Vitro Evaluation of Anti-breast Cancer and Anti-infection Effect

Mohammad Mazloum-Ardakani,Negar Shaker-Ardakani,Azra Ebadi
DOI: https://doi.org/10.1007/s10876-022-02349-9
2022-09-25
Journal of Cluster Science
Abstract:In the present study, four types of ZIF-8-encapsulated drug (drug@ZIF-8) composites were developed for the sustained release of three drugs in aqueous solution avoiding the use of organic solvent. The possibility of using ZIF-8 frameworks to study both hydrophilic and hydrophobic drug release kinetics was a primary goal of the current research. Additionally, dual encapsulation of two antibiotics was conducted to improve the synergistic effects of two drugs to fight against a broad spectrum of aerobic and anaerobic Gram-positive and Gram-negative bacteria. Morphological properties of the obtained composites were studied using X-ray diffraction (XRD), scanning electron microscopy (SEM), nitrogen adsorption, transmission electron microscopy (TEM), and FT-IR analysis. The hydrophobic anti-cancer drug 5-fluorouracil (5-FU), hydrophilic ciprofloxacin (CF) and metronidazole (MZ) drugs were loaded successfully into these ZIF-8 composites using a one-pot process. The obtained 5-FU-loaded ZIF-8 composites demonstrated pH sensitive properties according to drug release studies in cancer therapy. It was found that, compared to free 5-FU, 5-FU-loaded ZIF-8 were more toxic to all the cell lines. The percentage drug loading capacity of these drug-loaded ZIF-8 formulations ranged from 7 to 12.61%. In addition, the in vitro drug release from drug@ZIF-8 formulations was investigated in phosphate buffer medium by studying the experimental data with five kinetic equations which best fitted in the Peppas–Sahlin equation.
chemistry, inorganic & nuclear
What problem does this paper attempt to address?